US FDA calls for removal of all ranitidine products
New studies show NDMA impurity increases in some meds over time, and when stored at higher than room temperature
Author
Impact of COVID-19 on pharma supply chains
Sameer Sah, Partner and Varun Narayan, Senior Associate at Khaitan & Co highlight the need for a risk management framework in…
Cipla announces completion of phase-3 clinical study for generic version of GSK’s Advair Diskus
The study, completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400…
High incident cases of invasive pneumococcal disease in India is result of lack of country-wide…
Vaccination for pneumococcal disease was only introduced in children in late 2017 across three Indian states, and vaccination in…
Takeda Appoints New Country Head for India
Koki Sato, a seasoned biopharmaceutical leader with over 17 years of experience across geographies has been assigned as the new…
Biocon’s Insulin Manufacturing Facility in Malaysia Receives EIR from US FDA
The Inspection has been closed with a “VAI” (Voluntary Action Indicated) classification in the EIR, for the three observations…
Reducing India’s Import Dependence on APIs: A possible way out
Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…
Laurus Labs and Rising Pharma to collaborate on a clinical trial for preventive COVID-19 treatment
They will work with University of Minnesota to explore hydroxychloroquine as preventive treatment for coronavirus disease 2019
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
The company will also establish a new US Vaccine manufacturing capabilities and additional production capacity outside the US to…
Book Launch Alert: ‘Innovation And Financial Performance In Indian Pharmaceutical…
The book, authored by Mithun Nandy, provides information and insight on the important areas where different research and…